Flow-through test: Difference between revisions

Revision as of 09:37, 23 September 2012

Revision as of 22:45, 24 September 2012

Line 1:

{{AFC submission|t||ts=2012091914593520120919151135|u=AndreasZH|ns=5}} <!--- Important, do not remove this line before article has been created. --->

'''Flow-through tests''' are a type of diagnostic assay that allows users to test for the presence of a biomarker, usually a specific [[antibody|antibody]], in a sample such as blood. Detection of a specific biomarker aids in the diagnosis of and allows therapeutic action to be initiated quickly. The field of applications for this technology is wide, whereas generally all applications applying [[Lateral_flow_test| lateral flow tests]] can be replaced by flow-through assays. Commercial applications mainly target testing for infectious disease, both by viruses (e.g. [[HIV| HIV]], [[Hepatitis_C| Hepatitis C]], [[Hepatitis_B| Hepatitis B]] <ref name="medmira"> http://www.medmira.com/default.asp?mn=1.21.83.113</ref>

Line 41 ⟶ 43:

<!-- This will add a notice to the bottom of the page and won't blank it! The new template which says that your draft is waiting for a review will appear at the bottom; simply ignore the old (grey) drafted templates and the old (red) decline templates. A bot will update your article submission. Until then, please don't change anything in this text box and press "Save page". -->

{{AFC submission|||ts=20120919151135|u=AndreasZH|ns=5}}

<!-- This will add a notice to the bottom of the page and won't blank it! The new template which says that your draft is waiting for a review will appear at the bottom; simply ignore the old (grey) drafted templates and the old (red) decline templates. A bot will update your article submission. Until then, please don't change anything in this text box and press "Save page". -->

{{AFC submission|||ts=20120919151304|u=AndreasZH|ns=5}}